Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The ...ibute-to-highlight medbox">Africa Centres for Disease Control and Prevention (CDC) was officially inaugurated in January 2017 and will support countries commencing surveillance for serious infectious disease threats in Africa, including resistance. Review of the recent WHO GLASS report suggests that, while certain nations do have some surveillance systems in place, very few countries in Africa currently conduct effective routine surveillance.
African Journal of Laboratory MedicineISSN: (Online) 2225-2010, (Print) 2225-2002
more
Currently, Mauritius and Seychelles have 85 and 82 percent vaccination rates, respectively, surpassing the 70 percent target set by the WHO in 2021. Countries that have attained vaccination rates of... between 50 and 70 percent include Liberia
at 67 percent, Rwanda at 66 percent, Morocco at 62 percent, and Tunisia at 53 percent. Meanwhile, about 25.3 percent of the continent's population is fully vaccinated.
Africa has registered over 12 million COVID-19 cases since the beginning of the pandemic. The following countries have recorded the highest number of cases: Egypt, Ethiopia, Libya, Morocco, South Africa, and Tunisia
more
This document provides guidance for African Union Member States on actions to be taken to ensure they continue to meet all the health
needs of their citizens in accordance with achieving the objectives of the ...box">Africa Health Strategy 2016 – 2030.
more
Over the past weeks, there has been wide media attention on the risk of transmission of the novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] by asymptomatic individuals. This situation has also been extensively discussed on various platforms globally. The purpose of t...his position statement is for the Africa Centres for Diseases Control and Prevention (Africa CDC) to clarify the situation of transmission of SARS-CoV-2 by pre-asymptomatic and asymptomatic Individuals.
more
To help increase continental testing efforts and reduce COVID-19 transmission in Africa, Africa CDC...pan> has launched the Partnership to Accelerate COVID-19 Testing (PACT): Test, Trace, Treat. PACT will mobilize experts, community workers, supplies and other resources to TEST, TRACE and TREAT COVID-19 cases in a timely manner to minimize the impact of the pandemic on the Africa continent.
The material is available in English, French and Portuguese
more
To help increase continental testing efforts and reduce COVID-19 transmission in Africa, Africa CDC...an> has launched the Partnership to Accelerate COVID-19 Testing (PACT): Test, Trace, Treat. PACT will mobilize experts, community workers, supplies and other resources to TEST, TRACE and TREAT COVID-19 cases in a timely manner to minimize the impact of the pandemic on the Africa continent.
Available in English and French
more
O presente documento fornece orientações aos Estados-Membros da União Africana com base num pedido específico dos Estados-Membros de uma lista de controlo/orientação dos equipamentos de protecção individual (EPI) necessários aos profissiona...is de saúde e prestadores de cuidados para a pandemia da doença de Coronavírus de 2019 (COVID-19). Este documento foi sintetizado a partir dos dados actualmente disponíveis (1-6), tendo em conta o contexto africano e, como tal, pode ser adaptado ao contexto do país.
more
The Africa Centres for Disease Control ...class="attribute-to-highlight medbox">and Prevention (Africa CDC) is concerned about inaccurate information being distributed through traditional and social media regarding prevention and treatment of novel coronavirus disease (COVID-19).
more
The Africa Centres for Disease Control ...class="attribute-to-highlight medbox">and Prevention (Africa CDC) is concerned about inaccurate information being distributed through traditional and social media regarding prevention and treatment of novel coronavirus disease (COVID-19).
more
The African Centers for Disease Control and <...span class="attribute-to-highlight medbox">Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expand the local manufacture of vaccines, diagnostics, and therapeutics. Presently, less than one percent of vaccines administered on the continent are manufactured locally. This places a great burden on the health systems of African countries and reduces their ability to respond to pandemics and other health crises.
more
Africa Centers for Disease Control ...s="attribute-to-highlight medbox">and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patients. The investigators reported that administration of oral or injectable dexamethasone resulted in about one-third reduction in mortality among COVID-19 patientsi that required mechanical ventilation and about one-fifth for patients requiring oxygen.
more
It is intended for use among clinicians taking care of moderate to severe COVID-19 cases.
The COVID-19 outbreak has brought with it the need for improved critical care ...hlight medbox">for patients who develop severe disease. The majority of COVID-19 patients present with mild to moderate illness, 15% develop severe illness and about 5% develop critical conditions needing intensive care unit (ICU) care, requiring noninvasive or invasive ventilation
more
This document simplifies the WHO guidance on severe acute respiratory infection (SARI) treatment centres and is meant to be accessible to healthcare workers, policymakers ...ighlight medbox">and others who want
a quick overview of the key requirements for a COVID-19 isolation centre either within an existing facility or as a standalone centre.
more
The purpose of this document is to provide guidance on the use of pooled sample testing strategy in coronavirus disease (COVID-19)
testing laboratories of the African Union Member States for scalin...g up SARS-CoV-2 nucleic acid testing capacity with the available resources. The current document describes the effect of factors such as the prevalence of COVID-19 in the population to be tested, the homogeneity of pools, and the sensitivity of the molecular test in optimal pool size determination. It also highlights the importance of monitoring the prevalence of COVID-19 in a population to be tested and proper validation of the test, to limit the potential for false-negative results. Validation studies to determine the optimal pool size by testing laboratories are recommended as the optimum approach. A safe, simple ‘two-stage pooling’ option has been indicated in this guidance to be used by laboratories until such validation can be achieved.
more
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key obj...ectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensure African countries can access a sufficient share of the global vaccine supply.3. Remove barriers to widespread delivery and uptake of effective vaccines across Africa.
more
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin... for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently, there is:
1. No scientific evidence from pre-clinical studies on the therapeutic effect of ivermectin for the management of COVID-19;
2. No evidence of its clinical efficacy for the management of patients with asymptomatic, mild, moderate or severe COVID-19; and
3. No safety data regarding the use of ivermectin for COVID-19 in the majority of the published studies.
more
24 Nov. 2021; This guidance provides considerations and a series of options that can be used to inform country strategies to minimise risk associated with shortages of personal protective equipment (PPE).
Re-use ...medbox">and reprocessing of single use PPE must be a last-resort temporary measure that is implemented only until stocks are replenished (2).This remains an area of active research and further updates to this evidence base are anticipated.
more
This guidance will assist staff, students and caregivers in schools (including day care centres, pre-school, primary and secondary schools), higher... educational institutions (including universities, research institutes) and other educational institutions with how to address coronavirus disease 2019 (COVID-19) during different outbreak phases as defined in the Africa CDC Stepwise Response.
more